Clin2
NCT07331506Possibly a fitRecruiting

Early detection of breast cancer with a blood test

Breast Cancer DetectionBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer FemaleBreast Cancer - Ductal Carcinoma in Situ (DCIS)Breast Cancer - Infiltrating Ductal CarcinomaBreast Cancer With Low to Intermediate HER2 ExpressionBreast Cancer (Early Breast Cancer)Breast Cancer - Female

Part of Cancer, Skin clinical trials.

This trial tests a new blood test called Oncoliq to see if it can find breast cancer early. It compares results from people with breast cancer and people without cancer.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
40 years to 70 years
Study type
Observational

Who can take part

  • Be between 40 and 70 years old to join as a person with breast cancer, or between 50 and 70 as a healthy volunteer
  • Have a breast cancer diagnosis at any stage (if joining the cancer group)
  • Not have had surgery or any cancer treatment before joining
  • Have a signed consent form agreeing to take part
  • If you are in the control group, you must have had a normal mammogram and breast ultrasound (BI-RADS 1 or 2)
  • Must be able to give blood safely and understand the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06439940Recruiting
Early breast cancer detection with blood test

This study tests a new blood test (liquid biopsy) that looks for tiny molecules called microRNAs to find early signs of breast cancer. It aims to detect cancer before symptoms appear, using a simple blood draw during your regular mammogram visit.

El Palomar, Morón, Buenos Aires
NCT06876610Recruiting
Blood test for early breast cancer detection

This trial tests a blood test that looks for chemical changes in DNA to help diagnose breast cancer. It may offer a simpler way to detect cancer without needing a tissue sample.

Beijing, Beijing Municipality
NCT04353557Recruiting
Blood test monitoring in early-stage breast cancer

This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.

Chongqing, Chongqing Municipality
NCT07219277Recruiting
Blood test to detect breast cancer early in women

This study tests a new blood test that aims to find breast cancer early in women who are at higher risk or are going for routine screening. If you are a woman aged 30–75 and are scheduled for a mammogram, MRI, or breast ultrasound, you may be able to help validate this test.

Phoenix, Arizona
NCT06336928Recruiting
Blood test validation for breast cancer diagnosis

This study is testing a new blood test (liquid biopsy) to see if it can accurately detect breast cancer or track remission. If you are a woman getting a mammogram, have an abnormal finding, were recently diagnosed, or are in remission after treatment, you may be able to join and help validate this test.

Los Angeles, California
NCT07046260Recruiting
Blood test study for early cancer detection

This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.

Coronado, California

Hear when a new Breast Cancer Detection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.